|
|
||||
|
The Outlook
The Scientist 2005, 19(Supplement 2):S4
|
||||
|
|
||||
|
How will growing regulatory and financial pressures and an increasingly globalized labor market affect career prospects in pharma for life scientists? What key skills are required by people hoping to work in the new and growing field of pharmacogenomics? Is it really possible to create a start-up-style environment in a Big Pharma setting? This section answers these questions and many others with a series of articles outlining the big changes underway in Big Pharma and the effects on hiring within the industry.
|
(continued >>)
To continue reading this full article, you must be a subscriber to The Scientist.
You are only a few minutes away from unlimited access.
Subscribe to The Scientist to get unlimited access to our premium content
Get unlimited access to this article and over 20 years of The Scientist archives. You won’t miss a word – all for as little as $4.95. Subscribe now.The Scientist offers site licenses to institutions and organizations. Recommend us to your librarian and get online access through your place or work or study.